These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation. Fink N, Segev A, Barbash I, Bogdan A, Hamdan A, Mazin I, Maor E, Hay I, Guetta V, Fefer P. Catheter Cardiovasc Interv; 2016 Feb 01; 87(2):341-6. PubMed ID: 26010839 [Abstract] [Full Text] [Related]
26. A simple percutaneous technique for hemostasis and closure after transcatheter aortic valve implantation. Badawi RA, Collins TJ, Ramee SR. Catheter Cardiovasc Interv; 2012 Jan 01; 79(1):152-5. PubMed ID: 21990123 [Abstract] [Full Text] [Related]
27. Complications of the access during aortic valve implantation through transfemoral access. Alsac JM, Zegdi R, Blanchard D, Achouh P, Cholley B, Berrebi A, Julia P, Fabiani JN. Ann Vasc Surg; 2011 Aug 01; 25(6):752-7. PubMed ID: 21621377 [Abstract] [Full Text] [Related]
33. Randomized trial of surgical cutdown versus percutaneous access in transfemoral TAVR. Holper EM, Kim RJ, Mack M, Brown D, Brinkman W, Herbert M, Stewart W, Vance K, Bowers B, Dewey T. Catheter Cardiovasc Interv; 2014 Feb 15; 83(3):457-64. PubMed ID: 23703878 [Abstract] [Full Text] [Related]
35. Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation. El-Mawardy M, Schwarz B, Landt M, Sulimov D, Kebernik J, Allali A, Becker B, Toelg R, Richardt G, Abdel-Wahab M. EuroIntervention; 2017 Jan 20; 12(13):1667-1673. PubMed ID: 28106001 [Abstract] [Full Text] [Related]
37. Successful use of a left ventricular apical access and closure device for second-generation transapical aortic valve implantation. Conradi L, Seiffert M, Shimamura K, Schirmer J, Blankenberg S, Reichenspurner H, Diemert P, Treede H. Thorac Cardiovasc Surg; 2014 Sep 20; 62(6):498-502. PubMed ID: 24911901 [Abstract] [Full Text] [Related]
38. Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety. Mylotte D, Sudre A, Teiger E, Obadia JF, Lee M, Spence M, Khamis H, Al Nooryani A, Delhaye C, Amr G, Koussa M, Debry N, Piazza N, Modine T. JACC Cardiovasc Interv; 2016 Mar 14; 9(5):472-80. PubMed ID: 26965937 [Abstract] [Full Text] [Related]
39. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). Généreux P, Cohen DJ, Williams MR, Mack M, Kodali SK, Svensson LG, Kirtane AJ, Xu K, McAndrew TC, Makkar R, Smith CR, Leon MB. J Am Coll Cardiol; 2014 Mar 25; 63(11):1100-9. PubMed ID: 24291283 [Abstract] [Full Text] [Related]
40. Expandable sheath for transfemoral transcatheter aortic valve replacement: procedural outcomes and complications. Borz B, Durand E, Tron C, Godin M, Canville A, Hauville C, Cribier A, Eltchaninoff H. Catheter Cardiovasc Interv; 2014 May 01; 83(6):E227-32. PubMed ID: 24403004 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]